Literature DB >> 25588983

External validation of the HIT Expert Probability (HEP) score.

Lee Joseph, Marcelo P V Gomes, Firas Al Solaiman, Julie St John, Asuka Ozaki, Manjunath Raju, Manoj Dhariwal, Esther S H Kim1.   

Abstract

The diagnosis of heparin-induced thrombocytopenia (HIT) can be challenging. The HIT Expert Probability (HEP) Score has recently been proposed to aid in the diagnosis of HIT. We sought to externally and prospectively validate the HEP score. We prospectively assessed pre-test probability of HIT for 51 consecutive patients referred to our Consultative Service for evaluation of possible HIT between August 1, 2012 and February 1, 2013. Two Vascular Medicine fellows independently applied the 4T and HEP scores for each patient. Two independent HIT expert adjudicators rendered a diagnosis of HIT likely or unlikely. The median (interquartile range) of 4T and HEP scores were 4.5 (3.0, 6.0) and 5 (3.0, 8.5), respectively. There were no significant differences between area under receiver-operating characteristic curves of 4T and HEP scores against the gold standard, confirmed HIT [defined as positive serotonin release assay and positive anti-PF4/heparin ELISA] (0.74 vs 0.73, p = 0.97). HEP score ≥ 2 was 100 % sensitive and 16 % specific for determining the presence of confirmed HIT while a 4T score > 3 was 93 % sensitive and 35 % specific. In conclusion, the HEP and 4T scores are excellent screening pre-test probability models for HIT, however, in this prospective validation study, test characteristics for the diagnosis of HIT based on confirmatory laboratory testing and expert opinion are similar. Given the complexity of the HEP scoring model compared to that of the 4T score, further validation of the HEP score is warranted prior to widespread clinical acceptance.

Entities:  

Keywords:  Heparins; thrombocytopenia; thrombosis

Mesh:

Substances:

Year:  2015        PMID: 25588983     DOI: 10.1160/TH14-05-0472

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  6 in total

1.  What's new about heparin-induced thrombocytopenia type II.

Authors:  Yasser Sakr
Journal:  Intensive Care Med       Date:  2015-04-23       Impact factor: 17.440

2.  Prospective comparison of the HEP score and 4Ts score for the diagnosis of heparin-induced thrombocytopenia.

Authors:  Allyson M Pishko; Sara Fardin; Daniel S Lefler; Koosha Paydary; Rolando Vega; Gowthami M Arepally; Mark Crowther; Lawrence Rice; Douglas B Cines; Adam Cuker
Journal:  Blood Adv       Date:  2018-11-27

Review 3.  Unfractionated heparin versus low molecular weight heparins for avoiding heparin-induced thrombocytopenia in postoperative patients.

Authors:  Daniela R Junqueira; Liliane M Zorzela; Edson Perini
Journal:  Cochrane Database Syst Rev       Date:  2017-04-21

Review 4.  Heparin-Induced Thrombocytopenia and Thrombosis: Preventing your Thrombolysis Practice from Taking a HITT.

Authors:  Eric Wannamaker; Kimi Kondo; D Thor Johnson
Journal:  Semin Intervent Radiol       Date:  2017-12-14       Impact factor: 1.513

Review 5.  Functional Assays in the Diagnosis of Heparin-Induced Thrombocytopenia: A Review.

Authors:  Valentine Minet; Jean-Michel Dogné; François Mullier
Journal:  Molecules       Date:  2017-04-11       Impact factor: 4.411

6.  Identification of Heparin-Induced Thrombocytopenia in Surgical Critically Ill Patients by Using the HIT Expert Probability Score: An Observational Pilot Study.

Authors:  Guillaume Besch; Dejan Ilic; Marc Ginet; Clément d'Audigier; Philippe Nguyen; David Ferreira; Emmanuel Samain; Guillaume Mourey; Sebastien Pili-Floury
Journal:  J Clin Med       Date:  2022-03-10       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.